China Pharma Holdings, Inc. (CPHI)
USD 1.91
(-3.54%)
USD 1.91
(-3.54%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.41 Million USD | 0.0% |
| 2022 | - USD | -100.0% |
| 2021 | 5.29 Million USD | 485.49% |
| 2020 | 904.22 Thousand USD | -58.88% |
| 2019 | 2.19 Million USD | -49.6% |
| 2018 | 4.36 Million USD | -36.92% |
| 2017 | 6.91 Million USD | -19.96% |
| 2016 | 8.64 Million USD | -19.88% |
| 2015 | 10.78 Million USD | -5.43% |
| 2014 | 11.4 Million USD | -8.66% |
| 2013 | 12.48 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 30.96 Thousand USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 126.77 Thousand USD | 126.32% |
| 2002 | 56.01 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.4 Million USD | -0.17% |
| 2024 Q2 | 1.4 Million USD | -0.45% |
| 2023 Q3 | 1.45 Million USD | 1771.79% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | 77.55 Thousand USD | 0.0% |
| 2023 FY | 1.41 Million USD | 0.0% |
| 2023 Q4 | 1.41 Million USD | -2.73% |
| 2022 FY | - USD | -100.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q2 | 4.75 Million USD | -4.47% |
| 2022 Q1 | 4.97 Million USD | -6.08% |
| 2022 Q3 | - USD | -100.0% |
| 2021 Q1 | 852.19 Thousand USD | -5.75% |
| 2021 Q2 | 411.25 Thousand USD | -51.74% |
| 2021 Q3 | 64.76 Thousand USD | -84.25% |
| 2021 Q4 | 5.29 Million USD | 8074.2% |
| 2021 FY | 5.29 Million USD | 485.49% |
| 2020 Q3 | 939.78 Thousand USD | -64.98% |
| 2020 FY | 904.22 Thousand USD | -58.88% |
| 2020 Q1 | 2.14 Million USD | -2.59% |
| 2020 Q2 | 2.68 Million USD | 25.3% |
| 2020 Q4 | 904.22 Thousand USD | -3.78% |
| 2019 Q4 | 2.19 Million USD | 0.33% |
| 2019 Q1 | 4.59 Million USD | 5.27% |
| 2019 FY | 2.19 Million USD | -49.6% |
| 2019 Q2 | 4.31 Million USD | -6.05% |
| 2019 Q3 | 2.19 Million USD | -49.2% |
| 2018 Q3 | 4.36 Million USD | -35.74% |
| 2018 Q2 | 6.79 Million USD | -5.12% |
| 2018 FY | 4.36 Million USD | -36.92% |
| 2018 Q1 | 7.16 Million USD | 3.6% |
| 2018 Q4 | 4.36 Million USD | -0.14% |
| 2017 Q2 | 8.85 Million USD | 3.27% |
| 2017 Q1 | 8.57 Million USD | -0.78% |
| 2017 FY | 6.91 Million USD | -19.96% |
| 2017 Q4 | 6.91 Million USD | 0.59% |
| 2017 Q3 | 6.87 Million USD | -22.34% |
| 2016 Q2 | 10.23 Million USD | -2.94% |
| 2016 Q1 | 10.54 Million USD | -2.21% |
| 2016 FY | 8.64 Million USD | -19.88% |
| 2016 Q4 | 8.64 Million USD | -3.95% |
| 2016 Q3 | 8.99 Million USD | -12.11% |
| 2015 FY | 10.78 Million USD | -5.43% |
| 2015 Q4 | 10.78 Million USD | 14.21% |
| 2015 Q3 | 9.44 Million USD | -17.86% |
| 2015 Q2 | 11.49 Million USD | 0.33% |
| 2015 Q1 | 11.45 Million USD | 0.48% |
| 2014 Q2 | 12.99 Million USD | 0.11% |
| 2014 Q4 | 11.4 Million USD | 0.24% |
| 2014 FY | 11.4 Million USD | -8.66% |
| 2014 Q1 | 12.98 Million USD | 4.0% |
| 2014 Q3 | 11.37 Million USD | -12.47% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | 12.48 Million USD | 91.52% |
| 2013 FY | 12.48 Million USD | 0.0% |
| 2013 Q3 | 6.51 Million USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | 3.8 Billion USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | 30.96 Thousand USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 Q1 | 48.55 Thousand USD | -1.0% |
| 2003 FY | 126.77 Thousand USD | 126.32% |
| 2003 Q2 | 126.77 Thousand USD | 161.1% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | -100.0% |
| 2002 Q1 | 39.16 Thousand USD | -24.95% |
| 2002 Q2 | 56.01 Thousand USD | 43.03% |
| 2002 Q3 | 54.03 Thousand USD | -3.53% |
| 2002 Q4 | 49.04 Thousand USD | -9.24% |
| 2002 FY | 56.01 Thousand USD | 0.0% |
| 2001 Q4 | 52.18 Thousand USD | 19.4% |
| 2001 Q3 | 43.7 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| cbdMD, Inc. | 2.4 Million USD | 41.252% |
| cbdMD, Inc. | 2.4 Million USD | 41.252% |
| Zomedica Corp. | 1.81 Million USD | 22.167% |